Comment from Switch Bioworks

Summary: Switch Bioworks, an American biotechnology start-up, supports the development of a modernized, science-based regulatory framework for engineered microbes. They argue for a risk-focused approach that evaluates organisms relative to their wild-type counterparts, advocates for "organism-trait-mechanism of action" permitting, and seeks to reduce regulatory burdens and duplicative reviews with other agencies like the EPA.